Efficacy and safety of adding fluoxetine to the treatment regimen of hospitalized patients with non‐critical COVID‐19 pneumonia: A double‐blind randomized, placebo‐controlled clinical trial

• Main Authors: Faranak Sedighi (Author), Mehran Zarghami (Author), Fatemeh Alizadeh Arimi (Author), Mahmood Moosazadeh (Author), Shahram Ala (Author), Roya Ghasemian (Author), Hossein Mehravaran (Author), Forouzan Elyasi (Author)
• Format: Book
• Published: Wiley, 2023-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Introduction Selective serotonin reuptake inhibitors are considered the drugs, whose effectiveness in viral pandemics has been studied. The aim of this study was to evaluate of adding fluoxetine to the treatment regimen of patients with COVID‐19 pneumonia. Methods This study was a double‐bl...